Christiana Schernthaner1, Johannes Kraus2, Franz Danmayr2, Matthias Hammerer2, Jens Schneider3, Uta C Hoppe2, Bernhard Strohmer2. 1. Department of Cardiology, Paracelsus Medical University, Salzburger Landeskliniken, Muellner Hauptstrasse 48, 5020, Salzburg, Austria. c.schernthaner@salk.at. 2. Department of Cardiology, Paracelsus Medical University, Salzburger Landeskliniken, Muellner Hauptstrasse 48, 5020, Salzburg, Austria. 3. Department of Cardiac Surgery, Paracelsus Medical University, Salzburger Landeskliniken, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.
Abstract
BACKGROUND: Transcatheter aortic valve implantation (TAVI) is a less invasive technique for the treatment of severe aortic stenosis in high-risk patients. Occurrence of conduction disturbances requiring permanent pacemaker (PPM) implantation after TAVI is frequently observed. METHODS: The retrospective analysis comprised 153 patients (96 women, aged from 65 to 97 years) who underwent TAVI due to high-grade aortic stenosis. The aim was to evaluate the incidence of high-grade atrioventricular (AV) block after TAVI and the percentage of ventricular pacing and pacemaker (PM)-dependency at the first follow-up 6-8 weeks after implantation. RESULTS: Out of the 153 patients (age 81 ± 6 years) who underwent TAVI, 144 (94 %) had a transfemoral and 9 (6 %) patients a transapical approach. A PPM was implanted in 31 (20 %) patients, 24 (16 %) were implanted with the Medtronic CoreValve® and 7 (5 %) with the Edwards Sapien® valve (p = n.s.). Complete AV block was the indication in 21 patients (68 %), second-degree AV block in 1 patient (3 %), slow atrial fibrillation in 3 patients (10 %), new left bundle branch block (LBBB) plus sustained ventricular tachycardia (VT) in 1 patient (3 %), sick sinus syndrome in 2 patients (7 %), whereas in 3 patients (10 %) a PPM was inserted for safety reasons because of new LBBB and first-grade AV block. All of the nine patients (6 %) with a preexisting bundle branch block developed total AV block after TAVI. At follow-up PM-dependency (intrinsic rhythm < 30 bpm) occurred in 11/30 patients (37 %), whereas an intrinsic rhythm > 50 bpm was seen in 17 patients (57 %). At nominal device programming the percentage of ventricular stimulation (VP) during the short-term observation period was 60 ± 44 % in dual-chamber devices (N = 18), and 70 ± 36 % in single-chamber PPM (N = 5). CONCLUSION: The PPM implantation rate of about 20 % after TAVI is comparable to previously published data. The need for permanent pacing is linked to the valve type and preexistence of a right bundle branch block. At short-term more than half of the patients implanted with a device were not strictly PM-dependent, but presented an underlying intrinsic rhythm, indicating that temporary AV conduction disturbances may recover over time. This might justify a more conservative approach in some patients under watchful waiting. From another point of view, ventricular pacing at a regular or sensor-modulated rate may provide rhythm stability and chronotropy during the short-term period post-TAVI.
BACKGROUND: Transcatheter aortic valve implantation (TAVI) is a less invasive technique for the treatment of severe aortic stenosis in high-risk patients. Occurrence of conduction disturbances requiring permanent pacemaker (PPM) implantation after TAVI is frequently observed. METHODS: The retrospective analysis comprised 153 patients (96 women, aged from 65 to 97 years) who underwent TAVI due to high-grade aortic stenosis. The aim was to evaluate the incidence of high-grade atrioventricular (AV) block after TAVI and the percentage of ventricular pacing and pacemaker (PM)-dependency at the first follow-up 6-8 weeks after implantation. RESULTS: Out of the 153 patients (age 81 ± 6 years) who underwent TAVI, 144 (94 %) had a transfemoral and 9 (6 %) patients a transapical approach. A PPM was implanted in 31 (20 %) patients, 24 (16 %) were implanted with the Medtronic CoreValve® and 7 (5 %) with the Edwards Sapien® valve (p = n.s.). Complete AV block was the indication in 21 patients (68 %), second-degree AV block in 1 patient (3 %), slow atrial fibrillation in 3 patients (10 %), new left bundle branch block (LBBB) plus sustained ventricular tachycardia (VT) in 1 patient (3 %), sick sinus syndrome in 2 patients (7 %), whereas in 3 patients (10 %) a PPM was inserted for safety reasons because of new LBBB and first-grade AV block. All of the nine patients (6 %) with a preexisting bundle branch block developed total AV block after TAVI. At follow-up PM-dependency (intrinsic rhythm < 30 bpm) occurred in 11/30 patients (37 %), whereas an intrinsic rhythm > 50 bpm was seen in 17 patients (57 %). At nominal device programming the percentage of ventricular stimulation (VP) during the short-term observation period was 60 ± 44 % in dual-chamber devices (N = 18), and 70 ± 36 % in single-chamber PPM (N = 5). CONCLUSION: The PPM implantation rate of about 20 % after TAVI is comparable to previously published data. The need for permanent pacing is linked to the valve type and preexistence of a right bundle branch block. At short-term more than half of the patients implanted with a device were not strictly PM-dependent, but presented an underlying intrinsic rhythm, indicating that temporary AV conduction disturbances may recover over time. This might justify a more conservative approach in some patients under watchful waiting. From another point of view, ventricular pacing at a regular or sensor-modulated rate may provide rhythm stability and chronotropy during the short-term period post-TAVI.
Authors: Gerhard Schymik; Martin Heimeshoff; Peter Bramlage; Tanja Herbinger; Alexander Würth; Lothar Pilz; Jan S Schymik; Rainer Wondraschek; Tim Süselbeck; Jan Gerhardus; Armin Luik; Bernd-Dieter Gonska; Panagiotis Tzamalis; Herbert Posival; Claus Schmitt; Holger Schröfel Journal: Catheter Cardiovasc Interv Date: 2015-03-17 Impact factor: 2.692
Authors: Jeroen J Bax; Victoria Delgado; Vinayak Bapat; Helmut Baumgartner; Jean P Collet; Raimund Erbel; Christian Hamm; Arie P Kappetein; Jonathon Leipsic; Martin B Leon; Philip MacCarthy; Nicolo Piazza; Philippe Pibarot; William C Roberts; Josep Rodés-Cabau; Patrick W Serruys; Martyn Thomas; Alec Vahanian; John Webb; Jose Luis Zamorano; Stephan Windecker Journal: Eur Heart J Date: 2014-07-25 Impact factor: 29.983
Authors: Robert M A van der Boon; Nicolas M Van Mieghem; Dominic A Theuns; Rutger-Jan Nuis; Sjoerd T Nauta; Patrick W Serruys; Luc Jordaens; Ron T van Domburg; Peter P T de Jaegere Journal: Int J Cardiol Date: 2013-01-05 Impact factor: 4.164
Authors: David H Adams; Jeffrey J Popma; Michael J Reardon; Steven J Yakubov; Joseph S Coselli; G Michael Deeb; Thomas G Gleason; Maurice Buchbinder; James Hermiller; Neal S Kleiman; Stan Chetcuti; John Heiser; William Merhi; George Zorn; Peter Tadros; Newell Robinson; George Petrossian; G Chad Hughes; J Kevin Harrison; John Conte; Brijeshwar Maini; Mubashir Mumtaz; Sharla Chenoweth; Jae K Oh Journal: N Engl J Med Date: 2014-03-29 Impact factor: 91.245
Authors: Marina Urena; Salim Hayek; Asim N Cheema; Vicenç Serra; Ignacio J Amat-Santos; Luis Nombela-Franco; Henrique B Ribeiro; Ricardo Allende; Jean-Michel Paradis; Eric Dumont; Vinod H Thourani; Vasilis Babaliaros; Jaume Francisco Pascual; Carlos Cortés; Bruno García Del Blanco; François Philippon; Stamatios Lerakis; Josep Rodés-Cabau Journal: Circulation Date: 2014-12-02 Impact factor: 29.690
Authors: You Mi Hwang; Jun Kim; Gi Byoung Nam; Kee Joon Choi; Duk-Woo Park; Do-Yoon Kang; Seung-Jung Park; Seo Young Park Journal: Medicine (Baltimore) Date: 2021-06-04 Impact factor: 1.817
Authors: Esseim Sharma; Brian McCauley; Dhairyasheel S Ghosalkar; Michael Atalay; Scott Collins; Anshul Parulkar; Wasiq Sheikh; Malik B Ahmed; Antony Chu Journal: Cardiol Res Date: 2020-05-03
Authors: Korbinian Lackermair; Stephanie Fichtner; Bonnie Hartrampf; David Jochheim; Julius Steffen; Thomas Czermak; Sebastian Sadoni; Erik Lemmermöhle; Ina Klier; Heidi L Estner; Steffen Massberg; Julinda Mehilli Journal: Sci Rep Date: 2021-12-21 Impact factor: 4.379
Authors: Justine M Ravaux; Michele Di Mauro; Kevin Vernooy; Arnoud W Van't Hof; Leo Veenstra; Suzanne Kats; Jos G Maessen; Roberto Lorusso Journal: JTCVS Open Date: 2021-02-12
Authors: Roberto Scarsini; Giovanni L De Maria; Jubin Joseph; Lampson Fan; Thomas J Cahill; Rafail A Kotronias; Francesco Burzotta; James D Newton; Rajesh Kharbanda; Bernard Prendergast; Flavio Ribichini; Adrian P Banning Journal: J Am Heart Assoc Date: 2019-09-14 Impact factor: 5.501